Clairvest's book value was $1,196.9 million or $84.06 per share as at September 30, 2024, compared with $1,186.2 million or $81.02 per share as at June 30, 2024. For the quarter ended September 30, ...

LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Featured here, the Balance Sheet for Vivos Therapeutics Inc, which summarises the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its obesity candidate VK2735, even as the company posted better-than ...

Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most recent fundraising round.

A trust created while an individual is still alive is an inter vivos trust (living trust), while one established upon the death of the individual is a testamentary trust (will trust). Trusts are ...